Back to Main

Atossa Genetics prices IPO at $5, the midpoint of the range

By: Renaissance Capital
Posted: 11/7/2012 5:12:00 PM
Referenced Stocks: ATOS

Atossa Genetics, which develops diagnostic tests and treatments for breast cancer, raised $4 million by offering 800,000 shares at $5, the midpoint of the range of $4 to $6. Atossa Genetics plans to list on the NASDAQ under the symbol ATOS. Dawson James acted as the sole bookrunner on the deal.